133 related articles for article (PubMed ID: 847240)
1. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
2. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
3. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
4. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
[TBL] [Abstract][Full Text] [Related]
5. Abortifacient efficiency of 15 (S) 15-methyl-prostaglandin F2alpha-methyl ester administered vaginally during early pregnancy.
Ylikorkala O; Järvinen PA; Puukka M; Viinikka L
Prostaglandins; 1976 Oct; 12(4):609-24. PubMed ID: 973006
[TBL] [Abstract][Full Text] [Related]
6. Termination of early pregnancy by ONO-802 suppositories (16,16-dimethyl-trans-delta2-PGE1 methyl ester).
Takagi S; Sakata H; Yoshida T; Den K; Fujii TK; Amemiya H; Tomita M
Prostaglandins; 1978 May; 15(5):913-9. PubMed ID: 704915
[TBL] [Abstract][Full Text] [Related]
7. Early abortion by vaginal prostaglandin suppositories. Blood loss in relation to elimination of serum chorionic gonadotrophin, progesterone and estradiol-17 beta.
Hamberger L; Nilsson L; Björn-Rasmussen E; Atterfelt P; Wiqvist N
Contraception; 1978 Feb; 17(2):183-93. PubMed ID: 630888
[TBL] [Abstract][Full Text] [Related]
8. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester.
Ganguli AC; Gréen K; Bygdeman M
Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282
[TBL] [Abstract][Full Text] [Related]
9. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of vaginal delivery systems containing 15[s]15-methyl PGF2alpha methyl ester.
Spilman CH; Beuving DC; Forbes AD; Roseman TJ; Larion LJ
Prostaglandins; 1976; 12 Suppl():1-16. PubMed ID: 968060
[TBL] [Abstract][Full Text] [Related]
11. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
12. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
13. Serum hormone levels in women undergoing abortion with intra-amniotic, extra-amniotic or intra-muscular administration of 15(S) 15-methyl-prostaglandin F2alpha.
Puri CP; Rahman SA; Jain AK; Bhaduri R; Singh CM; Hingorani V; Laumas KR
Prostaglandins; 1976 May; 11(5):905-23. PubMed ID: 935519
[TBL] [Abstract][Full Text] [Related]
14. The current status of prostaglandins as abortifacients.
Brenner WE
Am J Obstet Gynecol; 1975 Oct; 123(3):306-28. PubMed ID: 810025
[TBL] [Abstract][Full Text] [Related]
15. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
Sher G; Katz M
Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
[TBL] [Abstract][Full Text] [Related]
16. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy.
Bygdeman M; Ganguli A; Kinoshita K; Lundström V; Green K; Bergström S
Contraception; 1977 Feb; 15(2):129-41. PubMed ID: 837687
[No Abstract] [Full Text] [Related]
17. Hormone changes occurring during second trimester abortion induced with 15 (S)-15-methyl prostaglandin F2alpha.
Corson SL; Gilbertson TJ; Sobota JT; Bolognese RJ
Prostaglandins; 1975 Jun; 9(6):975-83. PubMed ID: 1162096
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of orally administered extracts of Montanoa tomentosa in early human pregnancy.
Landgren BM; Aedo AR; Hagenfeldt K; Diczfalusy E
Am J Obstet Gynecol; 1979 Oct; 135(4):480-4. PubMed ID: 114055
[TBL] [Abstract][Full Text] [Related]
19. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
Lauersen NH; Wilson KH
Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
